O	O	0	1	A	A	B-NP	DT	O	2	NMOD	O
O	O	2	14	polymorphism	polymorphism	I-NP	NN	B-DNA	14	SUB	B-DNA
O	O	15	19	that	that	B-NP	WDT	O	2	NMOD	O
O	O	20	27	affects	affect	B-VP	VBZ	O	3	SBAR	O
T1	B-Protein	28	31	OCT	OCT	B-NP	NN	B-protein	8	NMOD	B-protein
T1	I-Protein	31	32	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T1	I-Protein	32	33	1	1	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	34	41	binding	binding	I-NP	NN	O	4	OBJ	O
O	O	42	44	to	to	B-PP	TO	O	8	NMOD	O
O	O	45	48	the	the	B-NP	DT	O	13	NMOD	O
T2	B-Protein	49	52	TNF	TNF	I-NP	NN	B-DNA	13	NMOD	B-DNA
T9	B-Entity	53	61	promoter	promoter	I-NP	NN	I-DNA	13	NMOD	I-DNA
T9	I-Entity	62	68	region	region	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	69	71	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	72	82	associated	associate	I-VP	VBN	O	14	VC	O
O	O	83	87	with	with	B-PP	IN	O	15	VMOD	O
O	O	88	94	severe	severe	B-NP	JJ	O	18	NMOD	O
O	O	95	102	malaria	malaria	I-NP	NN	O	16	PMOD	O
O	O	103	104	[	[	O	(	O	22	DEP	O
O	O	104	107	see	see	B-VP	VB	O	22	DEP	O
O	O	108	116	comments	comment	B-NP	NNS	O	20	OBJ	O
O	O	116	117	]	]	O	)	O	15	VMOD	O

O	O	119	126	Genetic	Genetic	B-NP	JJ	O	2	NMOD	O
O	O	127	136	variation	variation	I-NP	NN	O	7	SUB	O
O	O	137	139	in	in	B-PP	IN	O	2	NMOD	O
T10	B-Entity	140	148	cytokine	cytokine	B-NP	NN	B-DNA	6	NMOD	B-DNA
T10	I-Entity	149	157	promoter	promoter	I-NP	NN	I-DNA	6	NMOD	I-DNA
T10	I-Entity	158	165	regions	region	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	166	168	is	be	B-VP	VBZ	O	27	VMOD	O
O	O	169	179	postulated	postulate	I-VP	VBN	O	7	VC	O
O	O	180	182	to	to	I-VP	TO	O	10	VMOD	O
O	O	183	192	influence	influence	I-VP	VB	O	8	VMOD	O
O	O	193	207	susceptibility	susceptibility	B-NP	NN	O	10	OBJ	O
O	O	208	210	to	to	B-PP	TO	O	11	NMOD	O
O	O	211	220	infection	infection	B-NP	NN	O	12	PMOD	O
O	O	220	221	,	,	O	,	O	27	P	O
O	O	222	225	but	but	O	CC	O	27	VMOD	O
O	O	226	229	the	the	B-NP	DT	O	18	NMOD	O
O	O	230	239	molecular	molecular	I-NP	JJ	O	18	NMOD	O
O	O	240	250	mechanisms	mechanism	I-NP	NNS	O	27	SUB	O
O	O	251	253	by	by	B-PP	IN	O	18	NMOD	O
O	O	254	259	which	which	B-NP	WDT	O	19	PMOD	O
O	O	260	264	such	such	B-NP	JJ	O	22	NMOD	O
O	O	265	278	polymorphisms	polymorphism	I-NP	NNS	O	23	SUB	O
O	O	279	284	might	might	B-VP	MD	O	19	SBAR	O
O	O	285	291	affect	affect	I-VP	VB	O	23	VC	O
O	O	292	296	gene	gene	B-NP	NN	O	26	NMOD	O
O	O	297	307	regulation	regulation	I-NP	NN	O	24	OBJ	O
O	O	308	311	are	be	B-VP	VBP	O	0	ROOT	O
O	O	312	319	unknown	unknown	B-ADJP	JJ	O	27	PRD	O
O	O	319	320	.	.	O	.	O	27	P	O

O	O	321	328	Through	Through	B-PP	IN	O	0	ROOT	O
O	O	329	339	systematic	systematic	B-NP	JJ	O	4	NMOD	O
O	O	340	343	DNA	DNA	I-NP	NN	O	4	NMOD	O
O	O	344	356	footprinting	footprinting	I-NP	NN	O	1	PMOD	O
O	O	357	359	of	of	B-PP	IN	O	4	NMOD	O
O	O	360	363	the	the	B-NP	DT	O	5	PMOD	O
T3	B-Protein	364	367	TNF	TNF	I-NP	NN	B-protein	6	PMOD	B-protein
O	O	368	369	(	(	O	(	O	7	NMOD	O
O	O	369	377	encoding	encode	B-VP	VBG	O	20	VMOD	O
T4	B-Protein	378	384	tumour	tumour	B-NP	NN	B-protein	12	NMOD	B-protein
T4	I-Protein	385	393	necrosis	necrosis	I-NP	NN	I-protein	12	NMOD	I-protein
T4	I-Protein	394	400	factor	factor	I-NP	NN	I-protein	9	OBJ	I-protein
O	O	400	401	,	,	O	,	O	17	P	O
T5	B-Protein	402	405	TNF	TNF	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	405	406	)	)	O	)	O	17	NMOD	O
T11	B-Entity	407	415	promoter	promoter	B-NP	NN	O	17	NMOD	O
T11	I-Entity	416	422	region	region	I-NP	NN	O	9	OBJ	O
O	O	422	423	,	,	O	,	O	20	P	O
O	O	424	426	we	we	B-NP	PRP	O	20	SUB	O
O	O	427	431	have	have	B-VP	VBP	O	8	SBAR	O
O	O	432	442	identified	identify	I-VP	VBN	O	20	VC	O
O	O	443	444	a	a	B-NP	DT	O	25	NMOD	O
O	O	445	451	single	single	I-NP	JJ	O	25	NMOD	O
O	O	452	462	nucleotide	nucleotide	I-NP	NN	O	25	NMOD	O
O	O	463	475	polymorphism	polymorphism	I-NP	NN	O	21	OBJ	O
O	O	476	477	(	(	O	(	O	28	DEP	O
O	O	477	480	SNP	SNP	B-NP	NN	O	28	DEP	O
O	O	480	481	)	)	O	)	O	25	NMOD	O
O	O	482	486	that	that	B-NP	WDT	O	25	NMOD	O
O	O	487	493	causes	cause	B-VP	VBZ	O	29	SBAR	O
O	O	494	497	the	the	B-NP	DT	O	40	NMOD	O
T12	B-Entity	498	503	helix	helix	I-NP	NN	O	40	NMOD	O
T12	I-Entity	503	504	-	-	B-NP	HYPH	O	40	P	O
T12	I-Entity	504	508	turn	turn	I-NP	NN	O	40	NMOD	O
T12	I-Entity	508	509	-	-	B-NP	HYPH	O	40	P	O
T12	I-Entity	509	514	helix	helix	I-NP	NN	O	40	NMOD	O
O	O	515	528	transcription	transcription	I-NP	NN	O	40	NMOD	O
O	O	529	535	factor	factor	I-NP	NN	O	40	NMOD	O
T6	B-Protein	536	539	OCT	OCT	I-NP	NN	B-protein	40	NMOD	B-protein
T6	I-Protein	539	540	-	-	B-NP	HYPH	I-protein	43	SUB	I-protein
T6	I-Protein	540	541	1	1	I-NP	CD	I-protein	40	NMOD	I-protein
O	O	542	544	to	to	B-VP	TO	O	43	VMOD	O
O	O	545	549	bind	bind	I-VP	VB	O	30	VMOD	O
O	O	550	552	to	to	B-PP	TO	O	43	VMOD	O
O	O	553	554	a	a	B-NP	DT	O	47	NMOD	O
T13	B-Entity	555	560	novel	novel	I-NP	JJ	O	47	NMOD	O
T13	I-Entity	561	567	region	region	I-NP	NN	O	53	NMOD	O
O	O	568	570	of	of	B-PP	IN	O	47	NMOD	O
T14	B-Entity	571	578	complex	complex	B-NP	JJ	B-protein	50	NMOD	B-protein
T14	I-Entity	579	586	protein	protein	I-NP	NN	I-protein	48	PMOD	I-protein
O	O	586	587	-	-	B-NP	HYPH	O	53	NMOD	O
T15	B-Entity	587	590	DNA	DNA	I-NP	NN	O	53	NMOD	O
O	O	591	603	interactions	interaction	I-NP	NNS	O	44	PMOD	O
O	O	604	607	and	and	O	CC	O	30	VMOD	O
O	O	608	614	alters	alter	B-VP	VBZ	O	30	VMOD	O
O	O	615	619	gene	gene	B-NP	NN	O	57	NMOD	O
O	O	620	630	expression	expression	I-NP	NN	O	55	OBJ	O
O	O	631	633	in	in	B-PP	IN	O	57	NMOD	O
O	O	634	639	human	human	B-NP	JJ	B-cell_type	60	NMOD	B-cell_type
O	O	640	649	monocytes	monocyte	I-NP	NNS	I-cell_type	58	PMOD	I-cell_type
O	O	649	650	.	.	O	.	O	1	P	O

O	O	651	654	The	The	B-NP	DT	O	2	NMOD	O
T7	B-Protein	655	658	OCT	OCT	I-NP	NN	B-DNA	7	NMOD	B-DNA
T7	I-Protein	658	659	-	-	B-NP	HYPH	O	7	P	O
T7	I-Protein	659	660	1	1	I-NP	CD	O	7	NMOD	O
O	O	660	661	-	-	I-NP	HYPH	O	7	NMOD	O
O	O	661	668	binding	bind	I-NP	VBG	O	7	NMOD	O
O	O	669	677	genotype	genotype	I-NP	NN	O	17	SUB	O
O	O	677	678	,	,	O	,	O	7	P	O
O	O	679	684	found	find	B-VP	VBN	O	7	NMOD	O
O	O	685	687	in	in	B-PP	IN	O	9	VMOD	O
O	O	688	701	approximately	approximately	B-NP	RB	O	13	NMOD	O
O	O	702	703	5	5	I-NP	CD	O	11	AMOD	O
O	O	703	704	%	%	I-NP	NN	O	10	PMOD	O
O	O	705	707	of	of	B-PP	IN	O	13	NMOD	O
O	O	708	716	Africans	African	B-NP	NNS	O	14	PMOD	O
O	O	716	717	,	,	O	,	O	7	P	O
O	O	718	720	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	721	731	associated	associate	I-VP	VBN	O	17	VC	O
O	O	732	736	with	with	B-PP	IN	O	18	VMOD	O
O	O	737	745	fourfold	fourfold	B-NP	RB	O	21	AMOD	O
O	O	746	755	increased	increase	I-NP	VBN	O	22	NMOD	O
O	O	756	770	susceptibility	susceptibility	I-NP	NN	O	31	NMOD	O
O	O	771	773	to	to	B-PP	TO	O	22	NMOD	O
O	O	774	782	cerebral	cerebral	B-NP	JJ	O	25	NMOD	O
O	O	783	790	malaria	malaria	I-NP	NN	O	23	PMOD	O
O	O	791	793	in	in	B-PP	IN	O	22	NMOD	O
O	O	794	799	large	large	B-NP	JJ	O	28	NMOD	O
O	O	800	804	case	case	I-NP	NN	O	26	PMOD	O
O	O	804	805	-	-	O	HYPH	O	31	NMOD	O
O	O	805	812	control	control	B-NP	NN	O	31	NMOD	O
O	O	813	820	studies	study	I-NP	NNS	O	19	PMOD	O
O	O	821	823	of	of	B-PP	IN	O	31	NMOD	O
O	O	824	828	West	West	B-NP	JJ	O	34	AMOD	O
O	O	829	836	African	African	I-NP	JJ	O	37	AMOD	O
O	O	837	840	and	and	I-NP	CC	O	37	AMOD	O
O	O	841	845	East	East	I-NP	JJ	O	37	AMOD	O
O	O	846	853	African	African	I-NP	JJ	O	38	NMOD	O
O	O	854	865	populations	population	I-NP	NNS	O	32	PMOD	O
O	O	865	866	,	,	O	,	O	18	P	O
O	O	867	872	after	after	B-PP	IN	O	18	VMOD	O
O	O	873	883	correction	correction	B-NP	NN	O	40	PMOD	O
O	O	884	887	for	for	B-PP	IN	O	41	NMOD	O
O	O	888	893	other	other	B-NP	JJ	O	46	NMOD	O
O	O	894	899	known	know	I-NP	VBN	O	46	NMOD	O
T8	B-Protein	900	903	TNF	TNF	I-NP	NN	B-protein	46	NMOD	B-protein
O	O	904	917	polymorphisms	polymorphism	I-NP	NNS	O	50	NMOD	O
O	O	918	921	and	and	O	CC	O	50	NMOD	O
O	O	922	928	linked	link	B-NP	VBN	O	50	NMOD	O
T16	B-Entity	929	932	HLA	HLA	I-NP	NN	B-DNA	50	NMOD	B-DNA
T16	I-Entity	933	940	alleles	allele	I-NP	NNS	I-DNA	42	PMOD	I-DNA
O	O	940	941	.	.	O	.	O	17	P	O
